BERGEN, A.W.; KORCZAK, J.F.; WEISSBECKER,K.A.; ANDGOLDSTEIN, A.M.A genome-wide search for loci contributing to smoking and alcoholism. Genetic Epidemiology17(Suppl. 1):S55?60, 1999	10597412
BIERUT, L.J.; DINWIDDIE, S.H.; BEGLEITER, H.; ETAL.Familial transmission of substance dependence:Alcohol, marijuana, cocaine, and habitual smoking:A report from the Collaborative Study on the Geneticsof Alcoholism [see comments]. Archives of GeneralPsychiatry55:982?988, 1998.	9819063
BIERUT, L.J.; RICE, J.P.; EDENBERG, H.J.; ETAL.Family-based study of the association of the dopamineD2 receptor gene (DRD2) with habitual smoking.AmericanJournal of Medical Genetics90:299?302,2000.	10710227
BRESLAU, N.Psychiatric comorbidity of smokingand nicotine dependence. Behavior Genetics25:95?101, 1995.	7733862
BUCHOLZ, K.K.; CADORET, R.; CLONINGER, C.R.;ETAL.A new, semi-structured psychiatric interviewfor use in genetic linkage studies: A report on thereliability of the SSAGA. Journal of Studies on Alcohol55:149?158, 1994.	8189735
CHATTERJI, S.; SAUNDERS, J.B.; VRASTI, R.; ETAL.Reliability of the alcohol and drug modules of theAlcohol Use Disorder and Associated DisabilitiesInterview Schedule?Alcohol/Drug-Revised(AUDADIS?ADR): An international comparison.Drug & Alcohol Dependence47:171?185, 1997.	9306043
EDENBERGH, H.J.; FOROUD, T.; KOLLER, D.L.; ETAL.A family-based analysis of the association of thedopamine D2 receptor (DRD2) with alcoholism.Alcoholism: Clinical and Experimental Research 22(2):505?512, 1998.	9581660
FEIGHNER, J.P.; ROBINS, E.; GUZE, S.B.; ETAL.Diagnostic criteria for use in psychiatric research.Archives of General Psychiatry26:57?63, 1972.	5009428
FOROUD, T.; EDENBERG, H.J.; GOATE, A.; ETAL.Alcoholism susceptibility loci: Confirmation studiesin a replicate sample and further mapping. Alcoholism:Clinicaland Experimental Research24(7):933?945, 2000.	10923994
GLASSMAN, A.H.; HELZER, J.E.; COVEY, L.S.; ETAL.Smoking, smoking cessation, and major depres-sion. Journal of the American Medical Association264:1546?1549, 1990.	2395203
GRANT, B.F., ANDHARFORD, T.C. Comorbiditybetween DSM?IV alcohol use disorders and majordepression: Results of a national survey. Drug &Alcohol Dependence 39:197?206, 1995.	8556968
HEATH, A.C.; BUCHOLZ, K.K.; MADDEN, P.A.; ETAL.Genetic and environmental contributions toalcohol dependence risk in a national twin sample:Consistency of findings in women and men.Psychological Medicine27:1381?1396, 1997.	9403910
REICHT.; EDENBERG, H.J.; GOATE, A.; ETAL.Genome-wide search for genes affecting the risk foralcohol dependence. American Journal of MedicalGenetics(Neuropsychiatric Genetics) 81:207?215,1998.	9603606
SMITH, S.S.; O?HARA, B.F.; PERSICO, A.M.; ETAL.Genetic vulnerability to drug abuse: The D2 dopaminereceptor Taq I B1 restriction fragment length poly-morphism appears more frequently in polysubstanceabusers. Archives of General Psychiatry49:723?727,1992.	1355337
SPITZ, M.R.; SHI, H.; YANG, F.; ETAL.Case-con-trol study of the D2 dopamine receptor gene andsmoking status in lung cancer patients. Journal ofthe NationalCancer Institute90:358?363, 1998.	9498477
TRUE, W.R.; HEATH, A.C.; SHERRER, J.F.; ETAL.Genetic and environmental contributions to smok-ing. Addiction92:1277?1287, 1997.	9489045
TRUE, W.R.; XIAN, H.; SCHERRER, J.F.; ETAL.Common genetic vulnerability for nicotine andalcohol dependence in men. Archives of GeneralPsychiatry56:655?661, 1999.	10401514
KESSLER, R.C.; MCGONAGLE, K.A.; ZHAO, S.; ETAL. Lifetimeand 12-month prevalence of DSM?III?R psychiatric disorders inthe United States. Results from the National ComorbiditySurvey. Archives in General Psychiatry51(1):8?19, 1994.	8279933
WARNER, L.A.; KESSLER, R.C.; HUGHES, M.; ANTHONY, J.C.;ANDNELSON, C.B. Prevalence and correlates of drug use anddependence in the United States. Results from the NationalComorbidity Survey. Archives in General Psychiatry52(3):219?229, 1995.	7872850
3. Benita S, Benoit JP, Puisieux F, Thies C.Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci.1984;73:1721-1724.	6527243
4. Mathews BR, Nixon JR. Surface characteristicsof gelatin microcapsules by scanning electronmicroscopy. J Pharm Pharmacol.1974;26:383-384.	4153096
5. Bodmeier R, McGinity J. Polylactic acidmicrospheres containing quinidine base andquinidine sulphate prepared by the solventevaporation technique. I. Methods andmorphology. J Microencapsul. 1987;4:279-288.	3504509
7. De Smedt SC, Meyvis TKL, Van Oostveldt P,Demeester J. A new microphotolysis basedapproach for mapping the mobility of drugs inmicroscopic drug delivery devices. Pharm Res.1999;16:1639-1642.	10554110
8. Bouillot P, Babak V, Dellacherie E. Novelbioresorbable and bioeliminable surfactants formicrosphere preparation. Pharm Res.1999;16:148-154.	9950294
9. Adler J, Jayan A, Melia CD. A method forquantifying differential expansion withinhydrating hydrophilic matrixes by trackingembedded fluorescent microspheres. J PharmSci. 1999;88:371-377.	10052997
10. Rojas J, Pinto-Alphandary H, Leo E, PecquetS, Couvreur P, Gulik A, Fattal E. Apolysorbate-based non-ionic surfactant canmodulate loading and release of beta-lactoglobulin entrapped in multiphasepoly(DL-lactide-co-glycolide) microspheres.Pharm Res. 1999;16:255-260.	10100311
11. Caponetti G, Hrkach JS, Kriwet B, Poh M,Lotan N, Colombo P, Langer R. Microparticlesof novel branched copolymers of lactic acidand amino acids: preparation andcharacterization. J Pharm. Sci 1999;88:136-141.	9874715
12. Lamprecht A, Schï¿½fer UF, Lehr, CM.Characterisation of microcapsules by confocallaser scanning microscopy: analysis ofstructure, capsule wall composition and ofencapsulation rate. Eur J Pharm Biopharm.2000;49:1-9.	10613921
13. Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solventevaporation method. I. Effect of process andformulation variables on drug entrapment. JMicroencapsul. 1989;7:347-355.	2384837
14. Iwata M, McGinity JW. Preparation of multi-phase microspheres of poly(lactic acid) andpoly(lactic-co-glycolic acid) containing a W/Oemulsion by a multiple solvent evaporationtechnique. J Microencapsul. 1992;9:201-214.	1593404
15. Schreiber AB, Haimovich J. Quantitativefluorometric assay for detection andcharacterization of Fc receptors. Meth Enzymol.1983;93:147-155.	6865782
16. Luzzi LA, Gerraughty RJ. Effects of selectedvariables on the extractability of oils fromcoacervate capsules. J Pharm Sci.1964;53:429-431.	14189940
17. Mussellwhite PR. The surface properties of anoil-water emulsion stabilized by mixtures ofcasein and gelatin. J Colloid and InterfaceScience. 1966;21:99-102.	5906905
19. Nihant N, Schugens C, Grandfils C, Jerome R,Teyssie P. Polylactide microparticles preparedby double emulsion/evaporation technique. I.Effect of primary emulsion stability. PharmRes. 1994;11:1479-1484.	7855056
20. Sezer AD, Akbuga J. Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads. JMicroencapsul. 1999;16:195-203.	10080113
21. Hari PR, Chandy T, Sharma CP.Chitosan/calcium alginate microcapsules forintestinal delivery of nitrofurantoin. JMicroencapsul. 1996;13:319-329.	8860687
22. Murata Y, Toniwa S, Miyamoto E, KawashimaS. Preparation of alginate gel beads containingchitosan nicotinic acid salt and the functions.Eur J Pharm Biopharm. 1999;48:49-52.	10477328
1. Yamashita F, Bando H, Koyama Y, Kitagawa S,Takakura, Y, Hashida, M. In vivo and in vitro analysis ofskin penetration enhancement based on a two-layer modelwith polar and non-polar routes in the stratum corneum.Pharm Res. 1994;11:185-191.	8165175
2. Phillips CA, Michiniak BB. Transdermal delivery ofdrugs with differing lipophilicities using azone analogs asdermal penetration enhances. J Pharm Sci. 1995;84:1427-1437.	8748324
3. Flynn GL, Yalkowsky SH, Roseman TJ. Masstransport phenomena and models: theoretical concepts. JPharm Sci. 1974;63:479-510.	4828694
4. Ozawa T, Takahashi M. Skin hydration: Recent Advances. Acta Derm Venereol. Suppl. 1994;185:26-28.	8091923
5. Iazzo PA, Olsen RA, Seewald MJ, Powis G, Stier A,Van Dyke RA. Transient increases of intracellular Ca++induced by volatile anesthetics in rat hepatocytes. CellCalcium. 1990;11:515-524.	2265428
6. Reed PW, Lardy HA. A23187: A divalent Cation ionophore. J Biol Chem. 1972;247:6970.	4263618
7. Wallace BA. Gramicidin channels and pores. Ann RevBiophysic Chem. 1990; 19:127	1694667
8. Araki M, Inaba H, Kon S, Imai M, Mizuguchi T.Effects of volatile anesthetics on the calcium ionophoreA23187-mediated alterations in hepatic flow andmetabolism in the perfused liver in fasted rats. ActaAnesthesiol Scan. 1997;41:55-61.	9061115
9. Plakas SM, James MO. Bioavailability, metabolism,and renal excretion of benzoic acid in the channel catfish(Ictalurus punctatus). Drug Metab Dispos.1990;18(5):552-556.	1981701
10. French DL, Haglund BO, Himmelstein KJ, MaugerJW: Controlled release of substituted benzoic andnaphthoic acids using Carbopol gels: measurement ofdrug concentration profiles and correlation to release ratekinetics. Pharm Res. 1995;12(10):1513-1520.	8584491
11. Miller GR, Smith CA, Stauber WT. Determination offibrosis from cryostat sections using high performanceliquid chromatography: skeletal muscle. Histochem J.1999;31:89-94.	10416680
12. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem. 1959;234:466-468.	13641241
14. Lee CH, Vyavahare N, Zand R, Kruth H, SchoenFJ,Bianco R,. Levy RJ. Inhibition of aortic wallcalcification in bioprosthetic heart valves by ethanolpretreatment: Biochemical and biophysical mechanisms. JBiomed Mater Res. 1998;42(1):30-37.	9740004
